United States Biotechnology & Medical Research

Scribe Therapeutics Inc (SCTX)

Track

Over the past 90 days, Scribe Therapeutics, Inc. recorded three insider buy transactions totaling $84,990. Chief Financial Officer David Parrot and Chief Business Officer Svetlana Lucas were the primary participants, acquiring shares on July 23, 2026. These purchases occurred amid a 26.5% increase in the company's stock price over the same period.
Ticker: SCTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Scribe Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 28 Jul 2026
Value US$101,212.33 | Price 160.04 | Shares 53,161 (-26.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-28 2026-07-28 B Purchase
Aghazadeh Behzad
Non-Executive Director Large shareholder
53,161 -26.6%
160.04
US$101,212 		53,161 -26.6% 160.04 US$101,212
2026-07-29 2026-07-27 B Purchase
AH Bio Fund II, L.P.
Large shareholder
32,646 -31.0%
157.34
US$3,061,475 		32,646 -31.0% 157.34 US$3,061,475
2026-07-29 2026-07-27 B Purchase
1.5
GORDON CARL L
Non-Executive Director
83,028 +28.2%
463.36
US$1,753,799 		83,028 +28.2% 463.36 US$1,753,799
2026-07-29 2026-07-27 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director
1,000 +286.7%
15.00
US$100,000 		1,000 +286.7% 15.00 US$100,000
2026-07-28 2026-07-24 B Purchase
Aghazadeh Behzad
Non-Executive Director Large shareholder
1,000 +1.6%
22.31
US$100,000 		1,000 +1.6% 22.31 US$100,000
2026-07-28 2026-07-24 B Purchase
Aghazadeh Behzad
Non-Executive Director Large shareholder
1,000 +334.5%
15.00
US$100,000 		1,000 +334.5% 15.00 US$100,000
2026-07-27 2026-07-23 B Purchase
0.8
Lucas Svetlana

Chief Business Officer

Officer
1,000 +inf%
15.00
US$100,000 		1,000 +inf% 15.00 US$100,000
2026-07-27 2026-07-23 B Purchase
Parrot David

Chief Financial Officer

Officer
1,000 +inf%
15.00
US$100,000 		1,000 +inf% 15.00 US$100,000
2026-07-27 2026-07-23 B Purchase
Parrot David

Chief Financial Officer

Officer
1,000 +inf%
15.00
US$100,000 		1,000 +inf% 15.00 US$100,000
Explore more

More insider trading research around Scribe Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America